S&P 500   4,078.42 (+0.68%)
DOW   33,057.93 (+0.61%)
QQQ   317.89 (+0.70%)
AAPL   162.87 (+0.31%)
MSFT   284.13 (+0.03%)
META   209.84 (+0.96%)
GOOGL   102.55 (+1.65%)
AMZN   102.88 (+0.86%)
TSLA   200.89 (+2.87%)
NVDA   274.09 (+0.09%)
NIO   10.52 (+0.57%)
BABA   102.36 (-0.99%)
AMD   96.76 (-1.14%)
T   19.10 (+0.10%)
F   12.45 (+1.30%)
MU   61.21 (-2.98%)
CGC   1.77 (+0.39%)
GE   95.03 (+1.04%)
DIS   98.89 (+0.81%)
AMC   5.04 (+1.41%)
PFE   40.44 (+0.15%)
PYPL   74.97 (+0.78%)
NFLX   340.76 (+0.69%)
S&P 500   4,078.42 (+0.68%)
DOW   33,057.93 (+0.61%)
QQQ   317.89 (+0.70%)
AAPL   162.87 (+0.31%)
MSFT   284.13 (+0.03%)
META   209.84 (+0.96%)
GOOGL   102.55 (+1.65%)
AMZN   102.88 (+0.86%)
TSLA   200.89 (+2.87%)
NVDA   274.09 (+0.09%)
NIO   10.52 (+0.57%)
BABA   102.36 (-0.99%)
AMD   96.76 (-1.14%)
T   19.10 (+0.10%)
F   12.45 (+1.30%)
MU   61.21 (-2.98%)
CGC   1.77 (+0.39%)
GE   95.03 (+1.04%)
DIS   98.89 (+0.81%)
AMC   5.04 (+1.41%)
PFE   40.44 (+0.15%)
PYPL   74.97 (+0.78%)
NFLX   340.76 (+0.69%)
S&P 500   4,078.42 (+0.68%)
DOW   33,057.93 (+0.61%)
QQQ   317.89 (+0.70%)
AAPL   162.87 (+0.31%)
MSFT   284.13 (+0.03%)
META   209.84 (+0.96%)
GOOGL   102.55 (+1.65%)
AMZN   102.88 (+0.86%)
TSLA   200.89 (+2.87%)
NVDA   274.09 (+0.09%)
NIO   10.52 (+0.57%)
BABA   102.36 (-0.99%)
AMD   96.76 (-1.14%)
T   19.10 (+0.10%)
F   12.45 (+1.30%)
MU   61.21 (-2.98%)
CGC   1.77 (+0.39%)
GE   95.03 (+1.04%)
DIS   98.89 (+0.81%)
AMC   5.04 (+1.41%)
PFE   40.44 (+0.15%)
PYPL   74.97 (+0.78%)
NFLX   340.76 (+0.69%)
S&P 500   4,078.42 (+0.68%)
DOW   33,057.93 (+0.61%)
QQQ   317.89 (+0.70%)
AAPL   162.87 (+0.31%)
MSFT   284.13 (+0.03%)
META   209.84 (+0.96%)
GOOGL   102.55 (+1.65%)
AMZN   102.88 (+0.86%)
TSLA   200.89 (+2.87%)
NVDA   274.09 (+0.09%)
NIO   10.52 (+0.57%)
BABA   102.36 (-0.99%)
AMD   96.76 (-1.14%)
T   19.10 (+0.10%)
F   12.45 (+1.30%)
MU   61.21 (-2.98%)
CGC   1.77 (+0.39%)
GE   95.03 (+1.04%)
DIS   98.89 (+0.81%)
AMC   5.04 (+1.41%)
PFE   40.44 (+0.15%)
PYPL   74.97 (+0.78%)
NFLX   340.76 (+0.69%)
Top-Rated Stocks  
NASDAQ:GH

Guardant Health - GH News Today

$23.59
+0.67 (+2.92%)
(As of 03/31/2023 11:04 AM ET)
Add
Compare
Today's Range
$23.12
▼
$23.88
50-Day Range
$22.92
▼
$33.76
52-Week Range
$22.39
▼
$77.72
Volume
409,333 shs
Average Volume
1.99 million shs
Market Capitalization
$2.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.64
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.


GH Media Mentions By Week

GH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GH
News Sentiment
▼
1.43

0.60
▲
Average
Medical
News Sentiment

GH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GH Articles
This Week
▼
2

2
▲
GH Articles
Average Week

SourceHeadline
msn.com logoGuardant Health Earnings Perspective: Return On Capital Employed
msn.com - March 16 at 2:49 PM
finance.yahoo.com logoIn the wake of Guardant Health, Inc.'s (NASDAQ:GH) latest US$536m market cap drop, institutional owners may be forced to take severe actions
finance.yahoo.com - March 13 at 7:47 AM
msn.com logoCitigroup Downgrades Guardant Health (GH)
msn.com - March 10 at 4:51 PM
finance.yahoo.com logoGuardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield™ blood test
finance.yahoo.com - March 10 at 9:54 AM
msn.com logoExact upgraded, Guardant downgraded as Citi revisits diagnostics coverage
msn.com - March 9 at 6:52 PM
finance.yahoo.com logo2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market
finance.yahoo.com - March 6 at 9:59 AM
msn.com logoLooking Into Guardant Health's Return On Capital Employed
msn.com - March 1 at 2:32 AM
msn.com logoAnalyst Expectations for Guardant Health's Future
msn.com - February 27 at 5:47 PM
benzinga.com logoEarnings Outlook For Guardant Health
benzinga.com - February 22 at 6:25 PM
finance.yahoo.com logoDoes Guardant Health (GH) Have Attractive Growth Prospects in the Long-Term?
finance.yahoo.com - February 20 at 1:17 PM
wsj.com logoGuardant Health receives coverage from UnitedHealthcare for Guardant360(R) CDx blood test as companion diagnostic in advanced lung and breast cancer
wsj.com - February 8 at 3:12 PM
markets.businessinsider.com logoGoldman Sachs Keeps Their Buy Rating on Guardant Health (GH)
markets.businessinsider.com - February 6 at 2:11 PM
markets.businessinsider.com logoGuardant Health Says Illumina Has No Basis For Challenging Ownership Of Its Patents
markets.businessinsider.com - February 2 at 11:33 AM
technews.tmcnet.com logoMagistrate Judge Issues Favorable Recommendation Regarding Guardant Health's Motion to Dismiss Lawsuit Brought by Illumina
technews.tmcnet.com - February 2 at 6:33 AM
finance.yahoo.com logoMagistrate Judge Issues Favorable Recommendation Regarding Guardant Health’s Motion to Dismiss Lawsuit Brought by Illumina
finance.yahoo.com - February 2 at 6:33 AM
finance.yahoo.com logoGuardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
finance.yahoo.com - February 1 at 5:50 PM
finance.yahoo.com logoGuardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer
finance.yahoo.com - January 30 at 8:20 AM
finance.yahoo.com logoGuardant Health (NASDAQ:GH) investors are sitting on a loss of 59% if they invested three years ago
finance.yahoo.com - January 29 at 9:40 AM
seekingalpha.com logoGuardant Health: Positive ECLIPSE Data Signals More Upside
seekingalpha.com - January 20 at 10:28 AM
reuters.com logoGH.OQ - | Stock Price & Latest News | Reuters
reuters.com - January 18 at 4:53 PM
finance.yahoo.com logoGuardant Health to showcase new data at ASCO GI 2023 demonstrating utility of its blood tests for patients with gastrointestinal cancers
finance.yahoo.com - January 17 at 5:58 PM
msn.com logoGuardant health gains on guiding Q4 and FY22 revenue above estimates
msn.com - January 9 at 9:40 AM
finance.yahoo.com logoGuardant Health Looks Downright Sickly
finance.yahoo.com - December 28 at 12:38 PM
forbes.com logoIs A Rise Imminent For Guardant Health Stock After A 38% Fall In A Month?
forbes.com - December 21 at 9:31 AM
bizjournals.com logoGuardant Health lost 27% of its stock valuation after releasing study on its colorectal cancer blood test
bizjournals.com - December 16 at 10:34 PM
finance.yahoo.com logoMidday movers: Adobe Systems, Guardant Health, Meta Platforms and more
finance.yahoo.com - December 16 at 5:33 PM
msn.com logoExact at seven-month high as Guardant data for cancer screening test disappoints
msn.com - December 16 at 5:33 PM
proactiveinvestors.com logoGuardant Health stock plunges, Exact Sciences rises on contrasting colorectal cancer detection tests
proactiveinvestors.com - December 16 at 12:32 PM
msn.com logoGuardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
msn.com - December 16 at 7:31 AM
msn.com logoGuardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 39%
msn.com - December 15 at 8:10 PM
benzinga.com logoGuardant Health Recent Insider Activity
benzinga.com - November 18 at 7:37 PM
benzinga.com logoGuardant Health Unusual Options Activity
benzinga.com - November 15 at 9:50 PM
finance.yahoo.com logoGuardant Health Third Quarter 2022 Earnings: EPS Misses Expectations
finance.yahoo.com - November 9 at 8:09 AM
seekingalpha.com logoGuardant: A Temporary Exemption From The Gene Testing Market New Paradigm
seekingalpha.com - November 7 at 1:08 PM
finance.yahoo.com logoDown More Than 50%: These 3 “Strong Buy” Stocks Are Too Cheap to Ignore
finance.yahoo.com - November 1 at 1:08 PM
forbes.com logoBlood Test For Cancer Gives New Life To Guardant Health Shares
forbes.com - October 17 at 3:39 PM
seekingalpha.com logoGuardant: Saving Lives One Blood Test At A Time
seekingalpha.com - October 16 at 12:56 AM
seekingalpha.com logoGH Guardant Health, Inc.
seekingalpha.com - October 11 at 2:31 PM
health.usnews.com logoEast Jefferson General Hospital
health.usnews.com - October 11 at 4:31 AM
finance.yahoo.com logoGuardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
finance.yahoo.com - October 10 at 6:18 PM
finance.yahoo.com logoCancer-Detecting Blood Tests Behind Illumina’s $7.1 Billion Antitrust Battle Gain Ground
finance.yahoo.com - October 7 at 10:43 AM
finance.yahoo.com logoStephens Starts Coverage On This Precision Oncology Company With 66% Upside
finance.yahoo.com - October 6 at 7:21 PM
finance.yahoo.com logoWhy Guardant Health Topped the Market on Thursday
finance.yahoo.com - October 6 at 7:21 PM
nasdaq.com logoGH Crosses Above Key Moving Average Level
nasdaq.com - October 4 at 4:07 PM
nasdaq.com logoFirst Week of GH January 2025 Options Trading
nasdaq.com - September 13 at 12:09 PM
finance.yahoo.com logoGuardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner
finance.yahoo.com - September 9 at 6:53 PM
finance.yahoo.com logoGuardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients
finance.yahoo.com - September 6 at 10:21 AM
benzinga.com logoWhat Are Whales Doing With Guardant Health
benzinga.com - September 2 at 4:41 PM
tmcnet.com logoGuardant Health Expands Strategic Collaboration With Merck KGaA,
tmcnet.com - August 31 at 6:13 PM
barrons.com logoPremarket Movers: Chewy Cl A, HP, Guardant Health
barrons.com - August 31 at 8:57 AM
Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:GH) was last updated on 3/31/2023 by MarketBeat.com Staff